CONMED Corporation (CNMD) has a MoatMap StockRank of 87/100 based on Quality (57/100), Value (67/100), and Momentum (47/100) factor scores. The current signal is STRONG BUY. CONMED is a medical technology company. While it operates in a stable sector, it does not align with the CDMO pricing power cycle or any of our other high-conviction macro themes for the next 18 months.
CONMED Corporation is a global medical technology company specializing in the development and manufacture of surgical devices and equipment for minimally invasive procedures across various specialties. Its core products include solutions for arthroscopy, powered surgical instruments, and advanced energy, which address unmet clinical needs. The company's competitive edge lies in its innovation within niche surgical markets and its established relationships with surgical professionals worldwide.
| Price | $35.13 |
| Market Cap | $1.1B |
| P/E (TTM) | 19.85 |
| P/E (Forward) | 7.28 |
| Price/Book | 1.04 |
| Return on Equity | 5.5% |
| Return on Invested Capital | 5.1% |
| Debt/Equity | 84.59 |
| Gross Margin | 54.1% |
| Operating Margin | 10.0% |
| Revenue Growth | -1.3% |
| Dividend Yield | 2.3% |
| Free Cash Flow | $126M |
CONMED Corporation operates in the Medical Devices industry, part of the Healthcare sector (United States).